Cerus reported $-12208000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Cerulean Pharma CERU:US $ -8.4M 1.14M
Cerus CERS:US $ -12.21M 3.16M
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
GRIFOLS GRF:SM € 221M 44.67M
Haemonetics HAE:US $ 42.72M 11.85M
Orasure Technologies OSUR:US $ -16.03M 7.1M
Sientra SIEN:US $ -17.98M 2.13M
Terumo 4543:JP Y 21457M 6305M